Temporal trends of health disparity in the utilization of curative-intent treatments for hepatocellular carcinoma: are we making progress?

J Gastrointest Surg. 2024 Sep;28(9):1392-1399. doi: 10.1016/j.gassur.2024.05.015. Epub 2024 May 14.

Abstract

Background: Liver-directed treatments - ablative therapy (AT), surgical resection (SR), liver transplantation (LT), and transarterial chemoembolization (TACE) - improve the overall survival of patients with early-stage hepatocellular carcinoma (HCC). Although racial and socioeconomic disparities affect access to liver-directed therapies, the temporal trends for the curative-intent treatment of HCC remain to be elucidated.

Methods: This study performed chi-square, logistic regression, and temporal trends analyses on data from the Nationwide Inpatient Sample from 2011 to 2019. The outcome of interest was the rate of AT, SR, LT (curative-intent treatments), and TACE utilization, and the primary predictors were racial/ethnic group and socioeconomic status (SES; insurance status).

Results: African American and Hispanic patients had lower odds of receiving AT (African American: odds ratio [OR], 0.78; P < .001; Hispanic: OR, 0.84; P = .005) and SR (African American: OR, 0.71; P < .001; Hispanics: OR, 0.64; P < .001) than White patients. Compared with White patients, the odds of LT was lower in African American patients (OR, 0.76; P < .001) but higher in Hispanic patients (OR, 1.25; P = .001). Low SES was associated with worse odds of AT (OR, 0.79; P = .001), SR (OR, 0.66; P < .001), and LT (OR, 0.84; P = .028) compared with high SES. Although curative-intent treatments showed significant upward temporal trends among White patients (10.6%-13.9%; P < .001) and Asian and Pacific Islander/other patients (14.4%-15.7%; P = .007), there were nonsignificant trends among African American patients (10.9%-10.1%; P = .825) or Hispanic patients (12.2%-13.7%; P = .056).

Conclusion: Our study demonstrated concerning disparities in the utilization of curative-intent treatment for HCC based on race/ethnicity and SES. Moreover, racial/ethnic disparities have widened rather than improved over time.

Keywords: Access to care; Curative-intent treatment; Disparities; Hepatocellular carcinoma; Liver-directed therapy.

MeSH terms

  • Ablation Techniques / statistics & numerical data
  • Ablation Techniques / trends
  • Aged
  • Black or African American
  • Carcinoma, Hepatocellular* / ethnology
  • Carcinoma, Hepatocellular* / therapy
  • Chemoembolization, Therapeutic* / statistics & numerical data
  • Chemoembolization, Therapeutic* / trends
  • Female
  • Healthcare Disparities* / statistics & numerical data
  • Healthcare Disparities* / trends
  • Hepatectomy / statistics & numerical data
  • Hepatectomy / trends
  • Hispanic or Latino*
  • Humans
  • Insurance Coverage / statistics & numerical data
  • Liver Neoplasms* / ethnology
  • Liver Neoplasms* / therapy
  • Liver Transplantation* / statistics & numerical data
  • Liver Transplantation* / trends
  • Male
  • Middle Aged
  • United States
  • White